Stifel Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.2M | Sell |
|
|||||
|
2025
Q1 | $82.5M | Sell |
|
|||||
|
2024
Q4 | $131M | Sell |
|
|||||
|
2024
Q3 | $209M | Sell |
|
|||||
|
2024
Q2 | $253M | Buy |
|
|||||
|
2024
Q1 | $218M | Buy |
|
|||||
|
2023
Q4 | $168M | Buy |
|
|||||
|
2023
Q3 | $139M | Buy |
|
|||||
|
2023
Q2 | $121M | Sell |
|
|||||
|
2023
Q1 | $160M | Sell |
|
|||||
|
2022
Q4 | $164M | Sell |
|
|||||
|
2022
Q3 | $122M | Sell |
|
|||||
|
2022
Q2 | $138M | Buy |
|
|||||
|
2022
Q1 | $130M | Buy |
|
|||||
|
2021
Q4 | $117M | Buy |
|
|||||
|
2021
Q3 | $97.2M | Buy |
|
|||||
|
2021
Q2 | $81.3M | Buy |
|
|||||
|
2021
Q1 | $63.1M | Buy |
|
|||||
|
2020
Q4 | $56M | Buy |
|
|||||
|
2020
Q3 | $54M | Buy |
|
|||||
|
2020
Q2 | $50.1M | Buy |
|
|||||
|
2020
Q1 | $24.8M | Buy |
|
|||||
|
2019
Q4 | $18.1M | Buy |
|
|||||
|
2019
Q3 | $14.6M | Buy |
|
|||||
|
2019
Q2 | $13.1M | Sell |
|
|||||
|
2019
Q1 | $13.5M | Buy |
|
|||||
|
2018
Q4 | $11.1M | Sell |
|
|||||
|
2018
Q3 | $14.4M | Sell |
|
|||||
|
2018
Q2 | $15.3M | Sell |
|
|||||
|
2018
Q1 | $17.6M | Sell |
|
|||||
|
2017
Q4 | $19.5M | Buy |
|
|||||
|
2017
Q3 | $17.4M | Sell |
|
|||||
|
2017
Q2 | $16M | Buy |
|
|||||
|
2017
Q1 | $12.5M | Sell |
|
|||||
|
2016
Q4 | $17.4M | Sell |
|
|||||
|
2016
Q3 | $26.2M | Sell |
|
|||||
|
2016
Q2 | $44.9M | Sell |
|
|||||
|
2016
Q1 | $45.9M | Buy |
|
|||||
|
2015
Q4 | $48.5M | Sell |
|
|||||
|
2015
Q3 | $49.8M | Sell |
|
|||||
|
2015
Q2 | $51M | Buy |
|
|||||
|
2015
Q1 | $46M | Buy |
|
|||||
|
2014
Q4 | $35.4M | Buy |
|
|||||
|
2014
Q3 | $2.99M | Buy |
|
|||||
|
2014
Q2 | $1.48M | Buy |
|
|||||
|
2014
Q1 | $1.23M | Buy |
|